170 related articles for article (PubMed ID: 24510469)
1. An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.
Oguayo KN; Oyetayo OO; Costa SM; Mixon TA
Pharmacotherapy; 2014 May; 34(5):e30-3. PubMed ID: 24510469
[TBL] [Abstract][Full Text] [Related]
2. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
[TBL] [Abstract][Full Text] [Related]
4. Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity.
Nogales Asensio JM; Moreno Sánchez N; Doncel Vecino LJ; Villar Mariscal C; López-Mínguez JR; Merchán Herrera A
Int J Cardiol; 2007 Jan; 114(2):E65-7. PubMed ID: 17056139
[TBL] [Abstract][Full Text] [Related]
5. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
[TBL] [Abstract][Full Text] [Related]
6. Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia.
Ohki R; Takahashi M; Mizuno O; Fujikawa H; Mitsuhashi T; Katsuki T; Ikeda U; Shimada K
Pacing Clin Electrophysiol; 2001 Jan; 24(1):119-21. PubMed ID: 11227957
[TBL] [Abstract][Full Text] [Related]
7. [Acquired long QT syndrome and cardiac arrest after general anesthesia. Case report and review of literature].
Leclercq T; Parrel S; Mierdl S; Cottin Y; Girard C
Ann Fr Anesth Reanim; 2014 Jun; 33(6):421-6. PubMed ID: 24880555
[TBL] [Abstract][Full Text] [Related]
8. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
Lin JC; Quasny HA
Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
[TBL] [Abstract][Full Text] [Related]
9. Flecainide-associated bradycardia-dependent torsade de pointes: another potential mechanism of proarrhythmia.
Kim HS; Pak HN; Park JS; Kim SS
Pacing Clin Electrophysiol; 2013 Mar; 36(3):e84-6. PubMed ID: 21029131
[TBL] [Abstract][Full Text] [Related]
10. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P
Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
[TBL] [Abstract][Full Text] [Related]
11. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
12. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
13. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
Almroth H; Andersson T; Fengsrud E; Friberg L; Linde P; Rosenqvist M; Englund A
J Intern Med; 2011 Sep; 270(3):281-90. PubMed ID: 21635583
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
[TBL] [Abstract][Full Text] [Related]
15. Flecainide induced ventricular tachycardia (torsades de pointes).
Thevenin J; Da Costa A; Roche F; Romeyer C; Messier M; Isaaz K
Pacing Clin Electrophysiol; 2003 Sep; 26(9):1907-8. PubMed ID: 12930510
[TBL] [Abstract][Full Text] [Related]
16. Ventricular ectopy and QTc-interval prolongation associated with dronedarone therapy.
Gonzalez JE; Sauer WH; Krantz MJ
Pharmacotherapy; 2013 Oct; 33(10):e179-81. PubMed ID: 23836583
[TBL] [Abstract][Full Text] [Related]
17. Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate.
Dembek KA; Hurcombe SD; Schober KE; Toribio RE
J Vet Emerg Crit Care (San Antonio); 2014; 24(6):759-63. PubMed ID: 25388866
[TBL] [Abstract][Full Text] [Related]
18. Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy.
Doki K; Homma M; Kuga K; Kawano S; Aonuma K; Yamaguchi I; Kohda Y
J Clin Pharm Ther; 2007 Aug; 32(4):409-11. PubMed ID: 17635343
[TBL] [Abstract][Full Text] [Related]
19. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
Makai A; Rudas L; Liszkai G; Fazekas T
Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
[TBL] [Abstract][Full Text] [Related]
20. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
